Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Personnel File

    ATS Medical; Cambridge Heart; Coherex Medical; Escalon Medical; FlowCardia; Heartscape Technologies; InterCure; TherOx
  • Market updates

    Catheter ablation reduced the number of shocks delivered to patients who have defibrillators implanted after heart attacks, concluded a study published in late last month in the "New England Journal of Medicine".
  • Agreements

    Beckman Coulter; Thomas Jefferson University; Laboraf Diagnostica e Ricerca San Raffaele SpA; BioSphere Medical; DuPont Applied BioSciences; GE Healthcare; Draximage; Draxis Health; HemCon Medical Technologies; AutoMedx; Toshiba Medical Systems; TomTec Imaging Systems
  • Acquisitions

    Edwards Lifesciences; CardioVations Division of Ethicon; C.R. Bard; LeMaitre Vascular; Biomateriali; Sorin Group; MedCath; Heart Hospital of Lafayette; Heart Hospital of Acadiana; Volcano; CardioSpectra
  • New study finds in-hospital delays for defibrillation

    It has been fairly common to say that a shock with an automated external cardioverter (AED) must be given to someone experience cardiac arrest within a 10-minute window following initial attack.
  • Pharma developments

    A U.S. physician insists that current regulatory policies should be strengthened to ensure acceptable cardiovascular safety of medicines primarily developed for non-cardiovascular applications.
  • The CD&D Interview - Robert Jarvik, MD - Heart pump pioneer

    Robert Jarvik, MD, is a name known to many, for his development of the Jarvik 7 and the drama that was the life and death of retired dentist Barney Clark, the person first implanted with that first artificial heart in 1982.
  • Bristol Myers-Squibb sells cardiac imaging unit for $525 million

    Bristol-Myers Squibb (BMS; New York) reported in mid-December that it would sell its Medical Imaging (BMS-MI) unit in Billerica, Massachusetts, to private equity firm Avista Partners (New York) for $525 million in cash.
  • Business developments

    Boston Scientific (Natick, Massachusetts) reported that it has signed an agreement to sell its fluid management and venous access businesses for $425 million in cash to private equity firm Avista Capital Partners, thereby, it said last month, completing its program for spinning off what it termed "non-stategic" assets.
  • Abiomed provides European update

    Abiomed (Danvers, Massachusetts) rang in year 2008 by issuing an update to its European strategy to drive growth by establishing the concept of recovery as the goal for patients experiencing acute cardiac events.